This week Paul Chats with Carl Sedoryk, CEO of Monterey-Salinas Transit (MST) https://mst.org/ , about his jazz-themed BRT line, applying their new vision statement to serve the people who need transit the most better, and how his practice of martial arts makes him a better leader.

Monterey-Salinas Transit is in an interesting place, geographically and within the larger transit industry. Nestled on the Pacific coast and the Salinas Valley, Carl serves a unique community from tourists to farm workers. Carl and MST approach serving the community with their new vision statement as a guidepost: Connecting communities, creating opportunities, and being kind to the planet. Everything they do must check one of those three boxes (and hopefully more). From planning for zero emissions to adjusting routes to serve areas with high unemployment/low car ownership, Carl are changing how their system works.

Throughout this is an internal guide for Carl: his decades-long practice of martial arts. Hear what values he brings from his practice and how it helps him lead his agency.

Mike Bismeyer connects with kindness in MST's vision and then reflects on the recent APTA Transform Conference and EXPO. How he saw examples everywhere of people and leaders sharing and mentoring others.

Next week on the show we have an episode recorded live at APTA. It's a new CEO panel with Coree Cuff Lonergan, Dave Dech, Dottie Watkins, Frank White, and Tiffany Homler Hawkins reflecting on their first year as CEO at a major transit agency.

Questions/comments: [email protected].

Transit Unplugged is brought to you by Modaxo. Passionate about moving the world's people.

Enriched by Vizzy

(00:00) Carl Sedoryk Putting Riders and the Planet First

(00:02) Does the project match our mission and vision

(20:33) Mike's Minute with Mike Bismeyer

(22:12) What's coming up next week on Transit Unplugged

Chapters, images & show notes powered by vizzy.fm.

6 :51

• Monterey-Salinas Transit - Learn more about this unique transit district and its jazz-themed BRT line.

Modaxo 2025